Patents by Inventor Patrick J. Roddy

Patrick J. Roddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNE RESPONSE MODIFIER FORMULATIONS
    Publication number: 20100092401
    Abstract: The present invention provides a pharmaceutical foam formulation. Generally, the formulation includes a therapeutically effective amount of imiquimod and a fatty acid.
    Type: Application
    Filed: July 12, 2007
    Publication date: April 15, 2010
    Applicant: Graceway Pharmaceuticals, LLC
    Inventors: Janet A. Vallejo, Suzanne S. Leung, Patrick J. Roddy, Terri F. Busch
  • Gel formulations for topical drug delivery
    Patent number: 6365166
    Abstract: Pharmaceutical gel formulations for topical drug delivery include drug, colloidal silicon dioxide, triacetin and, preferably, propylene glycol. The gel formulations are well suited for topical delivery of the drug 4-amino-2-ethoxymethyl-&agr;,&agr;-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol, which when applied topically induces cytokines, such as interferon and tumor necrosis factor, locally in the skin or mucous membranes of a mammal. The gel formulations are also well-suited for topical delivery of drugs for treatment of diseases involving skin and/or mucosal lesions because the gel formulations do not need to include irritating components.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: April 2, 2002
    Assignee: 3M Innovative Properties Company
    Inventors: Joseph M. Beaurline, Patrick J. Roddy, Mark A. Tomai
  • GEL FORMULATIONS FOR TOPICAL DRUG DELIVERY
    Publication number: 20020015715
    Abstract: Pharmaceutical gel formulations for topical drug delivery include drug, colloidal silicon dioxide, triacetin and, preferably, propylene glycol. The gel formulations are well suited for topical delivery of the drug 4-amino-2-ethoxymethyl-&agr;,&agr;-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol, which when applied topically induces cytokines, such as interferon and tumor necrosis factor, locally in the skin or mucous membranes of a mammal. The gel formulations are also well-suited for topical delivery of drugs for treatment of diseases involving skin and/or mucosal lesions because the gel formulations do not need to include irritating components.
    Type: Application
    Filed: June 4, 1999
    Publication date: February 7, 2002
    Inventors: JOSEPH M. BEAURLINE, PATRICK J. RODDY, MARK A. TOMAI
  • Gel formulations for topical drug delivery
    Patent number: 5939090
    Abstract: Pharmaceutical gel formulations for topical drug delivery include drug, colloidal silicon dioxide, triacetin and, preferably, propylene glycol. The gel formulations are well suited for topical delivery of the drug 4-amino-2-ethoxymethyl-.alpha.,.alpha.-dimethyl-1H-imidazo?4,5-c!quinoline -1-ethanol, which when applied topically induces cytokines, such as interferon and tumor necrosis factor, locally in the skin or mucous membranes of a mammal. The gel formulations are also well-suited for topical delivery of drugs for treatment of diseases involving skin and/or mucosal lesions because the gel formulations do not need to include irritating components.
    Type: Grant
    Filed: December 3, 1996
    Date of Patent: August 17, 1999
    Assignee: 3M Innovative Properties Company
    Inventors: Joseph M. Beaurline, Patrick J. Roddy, Mark A. Tomai